According to a new study “Sustained cannabis use was associated with improvements in pain intensity, pain interference, sleep quality, subjective cognitive function, and reaction times” in cancer patients.
“Given the myriad of negative sequalae associated with cancer and its treatment, the palliative use of cannabis by cancer patients is increasingly of special interest”, states the study’s abstract, published in the journal Open Exploration. “This research sought to explore associations of acute and sustained use of legal market edible cannabis products on pain, cognition, and quality of life in a group of cancer patients.”
In this observational study, “cancer patients completed a baseline appointment, a two-week ad libitum cannabis use period, and an acute administration appointment that included assessments before cannabis use, one-hour post-use, and two-hour post-use.” Participants completed self-report questionnaires related to the primary outcomes and the Stroop task as a measure of objective cognitive function.
Continue reading